BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3768841)

  • 1. Influence of cellular DNA content on survival in differentiated thyroid cancer.
    Joensuu H; Klemi P; Eerola E; Tuominen J
    Cancer; 1986 Dec; 58(11):2462-7. PubMed ID: 3768841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular DNA pattern, S-phase frequency and survival in papillary thyroid cancer.
    Hrafnkelsson J; Stål O; Eneström S; Jonasson JG; Björnsson J; Olafsdottir K; Nordenskjöld B
    Acta Oncol; 1988; 27(4):329-33. PubMed ID: 3202993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular neoplasms of the thyroid in men older than 50 years of age. A DNA flow cytometric study.
    Hruban RH; Huvos AG; Traganos F; Reuter V; Lieberman PH; Melamed MR
    Am J Clin Pathol; 1990 Nov; 94(5):527-32. PubMed ID: 2239819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region.
    Onaran Y; Tezelman S; Gürel N; Terzioğlu T; Oğuz H; Tanakol R; Kapran Y
    Acta Chir Belg; 1999 Feb; 99(1):30-5. PubMed ID: 10090961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Flow cytometric DNA measurements of thyroid carcinomas].
    Tsuchiya A; Sekikawa K; Kimijima I; Suzuki S; Nihei M; Rokkaku Y; Abe R
    Gan No Rinsho; 1989 Jul; 35(8):886-90. PubMed ID: 2746864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric DNA analysis of thyroid carcinoma.
    Tsuchiya A; Sekikawa K; Ando Y; Suzuki S; Kimijima I; Abe R
    Jpn J Surg; 1990 Sep; 20(5):510-4. PubMed ID: 2243443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The measurement of DNA content and ploidy analysis in thyroid neoplasms.
    McLeod MK
    Otolaryngol Clin North Am; 1990 Apr; 23(2):271-90. PubMed ID: 2186336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA content in radiation-associated thyroid cancer.
    Komorowski RA; Deaconson TF; Vetsch R; Cerletty JM; Wilson SD
    Surgery; 1988 Dec; 104(6):992-6. PubMed ID: 3194850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ploidy and stromal bone formation as prognostic indicators of thyroid papillary carcinoma in aged patients: a retrospective study.
    Yamashita H; Noguchi S; Murakami N; Tsuji K; Yamaoka N; Sakamoto A
    Acta Pathol Jpn; 1993; 43(1-2):22-7. PubMed ID: 8465653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and degree of aneuploidy in benign and malignant thyroid neoplasms.
    Schelfhout LJ; Cornelisse CJ; Goslings BM; Hamming JF; Kuipers-Dijkshoorn NJ; van de Velde CJ; Fleuren GJ
    Int J Cancer; 1990 Jan; 45(1):16-20. PubMed ID: 2298499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric thyroid cancer.
    Sierk AE; Askin FB; Reddick RL; Thomas CG
    Pediatr Pathol; 1990; 10(6):877-93. PubMed ID: 2082334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric DNA measurement in benign and malignant human thyroid tissues.
    Mizukami Y; Nonomura A; Michigishi T; Kosaka T; Noguchi M; Nakamura S; Hashimoto T
    Anticancer Res; 1992; 12(6B):2213-7. PubMed ID: 1295468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of flow cytometry and histopathologic findings in thyroid follicular carcinomas and adenomas.
    Oyama T; Vickery AL; Preffer FI; Colvin RB
    Hum Pathol; 1994 Mar; 25(3):271-5. PubMed ID: 8150457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA aneuploidy in follicular thyroid neoplasia.
    Cusick EL; Ewen SW; Krukowski ZH; Matheson NA
    Br J Surg; 1991 Jan; 78(1):94-6. PubMed ID: 1998875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of nuclear DNA content in locally invasive and noninvasive papillary carcinoma of the thyroid gland.
    Stern Y; Lisnyansky I; Shpitzer T; Nativ O; Medalia O; Feinmesser R; Aronson M
    Otolaryngol Head Neck Surg; 1997 Nov; 117(5):501-3. PubMed ID: 9374174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA aneuploidy in follicular adenomas of the thyroid gland.
    Joensuu H; Klemi P; Eerola E
    Am J Pathol; 1986 Sep; 124(3):373-6. PubMed ID: 3766698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship among 201T1 uptake, nuclear DNA content and clinical behavior in metastatic thyroid carcinoma.
    Nakada K; Katoh C; Morita K; Kanegae K; Tsukamoto E; Shiga T; Mochizuki T; Tamaki N
    J Nucl Med; 1999 Jun; 40(6):963-7. PubMed ID: 10452311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA image cytometric analysis of differentiated thyroid adenocarcinoma specimens.
    Camargo RS; Scafuri AG; de Tolosa EM; Ferreira EA
    Am J Surg; 1992 Dec; 164(6):640-5. PubMed ID: 1463115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of nuclear DNA content in primary and metastatic differentiated thyroid carcinoma.
    Joensuu H; Klemi PJ
    Am J Clin Pathol; 1988 Jan; 89(1):35-40. PubMed ID: 3337050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours.
    Banito A; Pinto AE; Espadinha C; Marques AR; Leite V
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):706-11. PubMed ID: 17651453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.